Tirzepatide – Analytical Grade Dual GIP/GLP-1 Receptor Agonist

Our Tirzepatide is a high-purity, synthetic peptide complex designed for advanced metabolic research. It represents a novel class of compounds acting as a dual agonist for both the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This dual-action mechanism makes it an essential tool for scientists studying endocrine regulation and cellular metabolic signaling in controlled laboratory environments.

Molecular Profile and Synthesis Tirzepatide is a 39-amino acid modified peptide with a C20 fatty diacid moiety. This structural engineering is designed to enhance enzymatic stability and extend the half-life of the compound for prolonged observational studies. Our production process utilizes recombinant technology followed by rigorous purification to achieve a certified purity of 99% or higher, verified by HPLC (High-Performance Liquid Chromatography).

Primary Areas of Scientific Investigation Researchers utilize Tirzepatide in various in-vitro models to explore:

• Synergistic Incretin Activation: Analyzing the concurrent signaling of GIP and GLP-1 receptors.

• Glucose Homeostasis Pathways: Investigating the biochemical influence on insulin and glucagon secretion mechanisms.

• Metabolic Signaling Cascades: Studying the intracellular responses triggered by dual-agonist binding.

Laboratory Storage and Handling Each vial contains a stable, lyophilized powder. For long-term preservation, store at -20°C. Once reconstituted for research use, the solution should be refrigerated at 2°C to 8°C. Avoid mechanical agitation to protect the integrity of the peptide sequence.

⚠️ Research Use Only (RUO) This product is strictly for laboratory research and in-vitro analysis only. It is NOT a medication, drug, or food supplement and is NOT intended for human or veterinary use. It is not a weight loss product. Purchase is restricted to professional scientific use.